What is the treatment for secondary glaucoma?

• A. Treat Underlying Uveitis; Carbonic Anhydrase Inhibitors With Beta Blockers; AVOID Mitotic Agents Or Those That Create Uveitis
• B. Start Mitotic Agents To Reduce IOP
• C. Carbonic Anhydrase Inhibitors Alone
• D. Use Prostaglandin Analogs Exclusively

Answer: (A)

In secondary glaucoma, especially when it’s driven by inflammation such as uveitis, the approach must address both the underlying condition and the intraocular pressure. The best plan is to treat the uveitis itself to reduce inflammatory damage and then lower IOP with medications that limit aqueous production without worsening inflammation. Using a combination of a carbonic anhydrase inhibitor with a beta-blocker achieves that IOP reduction effectively and safely. Mitotic agents (like pilocarpine) can aggravate inflammation and promote synechiae, so they’re avoided. Relying solely on a single therapy like CAIs or using prostaglandin analogs exclusively doesn’t address the inflammatory source and can be less optimal in this scenario.